Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvy Laporte

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|April 6, 2012
Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort studyPatrick Mismetti, Charles-Marc Samama, Nadia Rosencher, et al.
European Journal of Clinical Pharmacology|March 27, 2012
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgeryXavier Delavenne, Paul Zufferey, Philippe Nguyen, et al.
Anesthesiology|October 27, 2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?Paul Zufferey, Fanette Merquiol, Silvy Laporte, et al.
Pharmacological Research|August 14, 2016
Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studiesSilvy Laporte, Céline Chapelle, Pascal Caillet, et al.
Plos One|March 23, 2017
Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyAurélie Di Bartolomeo, Céline Chauleur, Jean-Christophe Gris, et al.
Fundamental & Clinical Pharmacology|December 26, 2021
Clinical pharmacology: Current innovations and future challengesJean-Luc Cracowski, Jean-Sébastien Hulot, Silvy Laporte, et al.
Thrombosis and Haemostasis|March 8, 2003
Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trialSilvy Laporte, Sara Quenet, Andréa Buchmüller-Cordier, et al.
British Journal of Clinical Pharmacology|December 6, 2012
A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycinXavier Delavenne, Edouard Ollier, Thierry Basset, et al.
Plos One|March 14, 2014
Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillationJean-Christophe Lega, Laurent Bertoletti, Cyrielle Gremillet, et al.
Thrombosis and Haemostasis|November 1, 2013
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT studyIsabelle Gouin-Thibault, Claire Flaujac, Xavier Delavenne, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|April 6, 2012
Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort studyPatrick Mismetti, Charles-Marc Samama, Nadia Rosencher, et al.
European Journal of Clinical Pharmacology|March 27, 2012
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgeryXavier Delavenne, Paul Zufferey, Philippe Nguyen, et al.
Anesthesiology|October 27, 2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?Paul Zufferey, Fanette Merquiol, Silvy Laporte, et al.
Pharmacological Research|August 14, 2016
Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studiesSilvy Laporte, Céline Chapelle, Pascal Caillet, et al.
Plos One|March 23, 2017
Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyAurélie Di Bartolomeo, Céline Chauleur, Jean-Christophe Gris, et al.
Fundamental & Clinical Pharmacology|December 26, 2021
Clinical pharmacology: Current innovations and future challengesJean-Luc Cracowski, Jean-Sébastien Hulot, Silvy Laporte, et al.
Thrombosis and Haemostasis|March 8, 2003
Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trialSilvy Laporte, Sara Quenet, Andréa Buchmüller-Cordier, et al.
British Journal of Clinical Pharmacology|December 6, 2012
A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycinXavier Delavenne, Edouard Ollier, Thierry Basset, et al.
Plos One|March 14, 2014
Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillationJean-Christophe Lega, Laurent Bertoletti, Cyrielle Gremillet, et al.
Thrombosis and Haemostasis|November 1, 2013
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT studyIsabelle Gouin-Thibault, Claire Flaujac, Xavier Delavenne, et al.
Pageof 14